83 FR 39440 - Board of Scientific Counselors, National Institute for Occupational Safety and Health (BSC, NIOSH)
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention Federal Register Volume 83, Issue 154 (August 9, 2018)
Centers for Disease Control and Prevention
Federal Register Volume 83, Issue 154 (August 9, 2018)
| Page Range | 39440-39441 | |
| FR Document | 2018-17042 |
[Federal Register Volume 83, Number 154 (Thursday, August 9, 2018)] [Notices] [Pages 39440-39441] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-17042] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [Docket Number: NIOSH 278] Board of Scientific Counselors, National Institute for Occupational Safety and Health (BSC, NIOSH) AGENCY: Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. ----------------------------------------------------------------------- SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting of the Board of Scientific Counselors, National Institute for Occupational Safety and Health (BSC, NIOSH). This meeting is open to the public, limited only by the space available. The meeting room accommodates approximately 33 people. The meeting is also open to the public via webcast. If you wish to attend in person or by webcast, please see the NIOSH website to register (http://www.cdc.gov/niosh/bsc/) or call (404-498-2539) at least five business days in advance of the meeting. Teleconference is available toll-free; please dial (888) 397-9578, Participant Pass Code 63257516. Adobe Connect webcast will be available at https://odniosh.adobeconnect.com/nioshbsc/ for participants wanting to connect remotely. This meeting is open to the public, limited only by the space available. The public is welcome to participate during the public comment period, 12:30 p.m. to 12:45 p.m., EDT, September 27, 2018. Please note that the public comment period ends at the time indicated above. Each commenter will be provided up to five minutes for comment. A limited number of time slots are available and will be assigned on a first come-first served basis. Written comments will also be accepted from those unable to attend the public session via an on-line form at the following website: http://www.cdc.gov/niosh/bsc/contact.html. DATES: The meeting will be held on September 27, 2018, 8:30 a.m.-2:30 p.m., EDT. ADDRESSES: Patriots Plaza I, 395 E Street SW, Room 9000, Washington, DC 20201. FOR FURTHER INFORMATION CONTACT: Alberto Garcia, M.S., Executive Secretary, BSC, NIOSH, CDC, 1090 Tusculum Avenue, MS-R5, Cincinnati, OH 45226, telephone (513) 841-4596, fax (513) 841-4506, email: [email protected]. SUPPLEMENTARY INFORMATION: Purpose: The Secretary, the Assistant Secretary for Health, and by delegation the Director, Centers for Disease Control and Prevention, are authorized under Sections 301 and 308 of the Public Health Service Act to conduct directly or by grants or contracts, research, experiments, and demonstrations relating to occupational safety and health and to mine health. The Board of Scientific Counselors provides guidance to the Director, National Institute for Occupational Safety and Health on research and prevention programs. Specifically, the Board provides guidance on the Institute's research activities related to developing and evaluating hypotheses, systematically documenting findings and disseminating results. The Board evaluates the degree to which the activities of the National Institute for Occupational Safety and Health: (1) Conform to appropriate scientific standards, (2) address current, relevant needs, and (3) produce intended results. Matters to be Considered: The agenda for the meeting addresses occupational safety and health issues related to: NIOSH confronts the Opioid Crisis; 21st Century Surveillance Report; and Enhancing the Transparency of NIOSH Science. An agenda is also posted on the NIOSH website (http://www.cdc.gov/niosh/bsc/). Members of the public who wish to address the NIOSH BSC are requested to contact the Executive Secretary for scheduling purposes (see contact information below). Alternatively, written comments to the BSC may be submitted via an on- line form at the following website: http://www.cdc.gov/niosh/bsc/contact.html. Agenda items are subject to change as priorities dictate. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of [[Page 39441]] meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri A. Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2018-17042 Filed 8-8-18; 8:45 am] BILLING CODE 4163-18-P
![39440 Federal Register / Vol. 83, No. 154 / Thursday, August 9, 2018 / Notices
B. Federal Reserve Bank of Kansas 10045–0001. Comments can also be sent on a first come-first served basis.
City (Dennis Denney, Assistant Vice electronically to Written comments will also be accepted
President), 1 Memorial Drive, Kansas Comments.applications@ny.frb.org: from those unable to attend the public
City, Missouri 64198–0001: 1. Standard Chartered Bank, London, session via an on-line form at the
1. Kevin Page, Trustee of the Kevin England; through its subsidiary, following website: http://www.cdc.gov/
Page Trust, Fort Worth, Texas, Dana Standard Chartered Holdings, Inc., New niosh/bsc/contact.html.
Page, Co-Trustee of the Dana Page York, New York, to engage through a DATES: The meeting will be held on
Trust, Austin, Texas, Meghan Anderson newly formed entity, The Consortium, September 27, 2018, 8:30 a.m.–2:30
Smith, Co-Trustee of the Meghan LLC, in data processing activities, p.m., EDT.
Anderson Smith Trust, Fremont, pursuant to section 225.28(b)(14) of ADDRESSES: Patriots Plaza I, 395 E Street
Nebraska, Whitney Anderson, Co- Regulation Y. SW, Room 9000, Washington, DC 20201.
Trustee of the Whitney Anderson Trust,
Board of Governors of the Federal Reserve FOR FURTHER INFORMATION CONTACT:
Coppell, Texas, Eric Jones, Trustee of System, August 3, 2018. Alberto Garcia, M.S., Executive
the Eric Jones Trust, Blue Lake, Secretary, BSC, NIOSH, CDC, 1090
Ann Misback,
California, and Christopher Marious Tusculum Avenue, MS–R5, Cincinnati,
Secretary of the Board.
Jones, Co-Trustee of the Christopher OH 45226, telephone (513) 841–4596,
Marious Jones Trust, Los Angeles, [FR Doc. 2018–17010 Filed 8–8–18; 8:45 am]
BILLING CODE 6210–01–P
fax (513) 841–4506, email: agarcia1@
California; to retain shares of Page cdc.gov.
Bancshares, Inc., Liberty, Missouri, and
thereby retain shares of Pony Express SUPPLEMENTARY INFORMATION:
Bank, Braymer, Missouri. DEPARTMENT OF HEALTH AND Purpose: The Secretary, the Assistant
HUMAN SERVICES Secretary for Health, and by delegation
Board of Governors of the Federal Reserve the Director, Centers for Disease Control
System, August 6, 2018.
Centers for Disease Control and and Prevention, are authorized under
Yao-Chin Chao, Prevention Sections 301 and 308 of the Public
Assistant Secretary of the Board. Health Service Act to conduct directly
[FR Doc. 2018–17094 Filed 8–8–18; 8:45 am] [Docket Number: NIOSH 278]
or by grants or contracts, research,
BILLING CODE P
Board of Scientific Counselors, experiments, and demonstrations
National Institute for Occupational relating to occupational safety and
Safety and Health (BSC, NIOSH) health and to mine health. The Board of
FEDERAL RESERVE SYSTEM Scientific Counselors provides guidance
AGENCY: Centers for Disease Control and to the Director, National Institute for
Notice of Proposals To Engage in or Prevention (CDC), Department of Health Occupational Safety and Health on
To Acquire Companies Engaged in and Human Services (HHS). research and prevention programs.
Permissible Nonbanking Activities Specifically, the Board provides
ACTION: Notice of meeting.
The companies listed in this notice guidance on the Institute’s research
have given notice under section 4 of the SUMMARY: In accordance with the activities related to developing and
Bank Holding Company Act (12 U.S.C. Federal Advisory Committee Act, the evaluating hypotheses, systematically
1843) (BHC Act) and Regulation Y, (12 CDC announces the following meeting documenting findings and
CFR part 225) to engage de novo, or to of the Board of Scientific Counselors, disseminating results. The Board
acquire or control voting securities or National Institute for Occupational evaluates the degree to which the
assets of a company, including the Safety and Health (BSC, NIOSH). This activities of the National Institute for
companies listed below, that engages meeting is open to the public, limited Occupational Safety and Health: (1)
either directly or through a subsidiary or only by the space available. The meeting Conform to appropriate scientific
other company, in a nonbanking activity room accommodates approximately 33 standards, (2) address current, relevant
that is listed in § 225.28 of Regulation Y people. The meeting is also open to the needs, and (3) produce intended results.
(12 CFR 225.28) or that the Board has public via webcast. If you wish to attend Matters to be Considered: The agenda
determined by Order to be closely in person or by webcast, please see the for the meeting addresses occupational
related to banking and permissible for NIOSH website to register (http:// safety and health issues related to:
bank holding companies. Unless www.cdc.gov/niosh/bsc/) or call (404– NIOSH confronts the Opioid Crisis; 21st
otherwise noted, these activities will be 498–2539) at least five business days in Century Surveillance Report; and
conducted throughout the United States. advance of the meeting. Teleconference Enhancing the Transparency of NIOSH
Each notice is available for inspection is available toll-free; please dial (888) Science. An agenda is also posted on the
at the Federal Reserve Bank indicated. 397–9578, Participant Pass Code NIOSH website (http://www.cdc.gov/
The notice also will be available for 63257516. Adobe Connect webcast will niosh/bsc/). Members of the public who
inspection at the offices of the Board of be available at https:// wish to address the NIOSH BSC are
Governors. Interested persons may odniosh.adobeconnect.com/nioshbsc/ requested to contact the Executive
express their views in writing on the for participants wanting to connect Secretary for scheduling purposes (see
question whether the proposal complies remotely. This meeting is open to the contact information below).
with the standards of section 4 of the public, limited only by the space Alternatively, written comments to the
BHC Act. available. The public is welcome to BSC may be submitted via an on-line
participate during the public comment
sradovich on DSK3GMQ082PROD with NOTICES
Unless otherwise noted, comments form at the following website: http://
regarding the applications must be period, 12:30 p.m. to 12:45 p.m., EDT, www.cdc.gov/niosh/bsc/contact.html.
received at the Reserve Bank indicated September 27, 2018. Please note that the Agenda items are subject to change as
or the offices of the Board of Governors public comment period ends at the time priorities dictate.
not later than August 23, 2018. indicated above. Each commenter will The Director, Management Analysis
A. Federal Reserve Bank of New York be provided up to five minutes for and Services Office, has been delegated
(Ivan Hurwitz, Vice President) 33 comment. A limited number of time the authority to sign Federal Register
Liberty Street, New York, New York slots are available and will be assigned notices pertaining to announcements of
VerDate Sep<11>2014 18:11 Aug 08, 2018 Jkt 244001 PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 E:\FR\FM\09AUN1.SGM 09AUN1](https://thefederalregister.org/doc/83_FR_39594/page/1.svg)
![Federal Register / Vol. 83, No. 154 / Thursday, August 9, 2018 / Notices 39441
meetings and other committee DEPARTMENT OF HEALTH AND FDA to conduct research relating to
management activities, for both the HUMAN SERVICES drugs and other FDA regulated products
Centers for Disease Control and in carrying out the provisions of the
Prevention and the Agency for Toxic Food and Drug Administration FD&C Act.
Substances and Disease Registry. FDA regulates prescription drug
[Docket No. FDA–2017–N–0558]
advertising and promotional labeling
Sherri A. Berger, directed to healthcare professionals
Agency Information Collection
Chief Operating Officer, Centers for Disease (HCPs) and consumers (section 502(a)
Control and Prevention. Activities; Submission for Office of
Management and Budget Review; and (n), respectively, of the FD&C Act
[FR Doc. 2018–17042 Filed 8–8–18; 8:45 am] (21 U.S.C. 352(a) and (n))). In the course
Comment Request; Disclosures in
BILLING CODE 4163–18–P
Professional and Consumer of promoting their products,
Prescription Drug Promotion pharmaceutical sponsors (sponsors) may
present a variety of information
DEPARTMENT OF HEALTH AND AGENCY: Food and Drug Administration, including the indication, details about
HUMAN SERVICES HHS. the administration of the product,
ACTION: Notice. efficacy information, and clinical trial
Centers for Disease Control and data. To present often complicated
Prevention SUMMARY: The Food and Drug information concisely, sponsors may not
Administration (FDA) is announcing include relevant information in the
Notice of Closed Meeting that a proposed collection of body of the text or visual display of the
information has been submitted to the claim. Additionally, sponsors may not
In accordance with Section 10(a)(2) of
Office of Management and Budget always present limitations to the claim
the Federal Advisory Committee Act
(OMB) for review and clearance under in the main body of the text or display.
(Pub. L. 92–463), the Centers for Disease
the Paperwork Reduction Act of 1995 In these cases, sponsors typically
Control and Prevention (CDC)
(PRA). include disclosures of information
announces the following meeting.
The meeting will be closed to the DATES: Fax written comments on the somewhere in the promotional piece.
collection of information by September There is limited published research
public in accordance with provisions set
10, 2018. on disclosures in prescription drug
forth in Section 552b(c) (4) and (6), Title
ADDRESSES: To ensure that comments on promotion, either directed to consumers
5 U.S.C., and the Determination of the or to HCPs. The use of disclosures is one
Director, Management Analysis and the information collection are received,
OMB recommends that written method of communicating information
Services Office, CDC, pursuant to Public to HCPs and consumers about scientific
Law 92–463. comments be faxed to the Office of
Information and Regulatory Affairs, and clinical data, the limitations of that
Name of Committee: Safety and data, and practical utility of that
Occupational Health Study Section OMB, Attn: FDA Desk Officer, Fax: 202–
395–7285, or emailed to oira_ information. These disclosures may
(SOHSS), National Institute for influence HCP and consumer
Occupational Safety and Health submission@omb.eop.gov. All
comments should be identified with the comprehension and decision making,
(NIOSH). and may affect how and what treatment
OMB control number 0910–NEW and
Dates: October 16–October 18, 2018. title ‘‘Disclosures in Professional and HCPs prescribe for their patients.
Time: 8:00 a.m.–5:00 p.m., EDT. Consumer Prescription Drug Previous research on the effectiveness of
Promotion.’’ Also include the FDA disclosures has been conducted
Place: Embassy Suites, 1900 Diagonal
primarily in the dietary supplement
Road, Alexandria, VA 22314. docket number found in brackets in the
arena (Refs. 1–4). Thus, the proposed
Agenda: The meeting will convene to heading of this document.
research will examine the effectiveness
address matters related to the conduct of FOR FURTHER INFORMATION CONTACT: Ila
of clear and conspicuous disclosures in
Study Section business and for the S. Mizrachi, Office of Operations, Food prescription drug promotion directed to
study section to consider safety and and Drug Administration, Three White both populations. The purpose of our
occupational health-related grant Flint North, 10A–12M, 11601 study is to determine how useful
applications. Landsdown St., North Bethesda, MD disclosures regarding prescription drug
For Further Information Contact: Nina 20852, 301–796–7726, PRAStaff@ information are when presented
Turner, Ph.D., Scientific Review Officer, fda.hhs.gov. prominently and adjacent to claims.1
NIOSH, 1095 Willowdale Road, SUPPLEMENTARY INFORMATION: In Specifically, are HCPs and consumers
Morgantown, WV 26506, (304) 285– compliance with 44 U.S.C. 3507, FDA able to use disclosures to effectively
5976; nturner@cdc.gov. has submitted the following proposed frame information in efficacy claims in
The Director, Management Analysis collection of information to OMB for prescription drug promotion?
and Services Office, has been delegated review and clearance. To address this research question, we
the authority to sign Federal Register have designed a set of studies that cover
Disclosures in Professional and both consumers and HCPs, as well as
notices pertaining to announcements of Consumer Prescription Drug Promotion
meetings and other committee three presentations addressing different
management activities, for both the OMB Control Number 0910–NEW
1 The Federal Trade Commission (FTC), which
Centers for Disease Control and I. Background regulates the advertising of non-prescription drug
sradovich on DSK3GMQ082PROD with NOTICES
Prevention and the Agency for Toxic products as well as other non-FDA regulated
Substances and Disease Registry. Section 1701(a)(4) of the Public products (e.g., package goods, cars, etc.) issued a
Health Service Act (42 U.S.C. specific position on disclosures (Ref. 5) for the
Sherri Berger, 300u(a)(4)) authorizes FDA to conduct advertising it regulates. Specifically, FTC explains
Chief Operating Officer, Centers for Disease research relating to health information. that disclosures must be ‘‘clear and conspicuous’’;
Control and Prevention. in other words, in understandable language, located
Section 1003(d)(2)(C) of the Federal near the claim to be further clarified, and not
[FR Doc. 2018–17043 Filed 8–8–18; 8:45 am] Food, Drug, and Cosmetic Act (FD&C hidden or minimized by small font or other
BILLING CODE 4163–18–P Act) (21 U.S.C. 393(d)(2)(C)) authorizes distractions.
VerDate Sep<11>2014 18:11 Aug 08, 2018 Jkt 244001 PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 E:\FR\FM\09AUN1.SGM 09AUN1](https://thefederalregister.org/doc/83_FR_39594/page/2.svg)
Document Created: 2018-08-09 01:10:52
Document Modified: 2018-08-09 01:10:52
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of meeting. | |
| Dates | The meeting will be held on September 27, 2018, 8:30 a.m.-2:30 p.m., EDT. | |
| Contact | Alberto Garcia, M.S., Executive Secretary, BSC, NIOSH, CDC, 1090 Tusculum Avenue, MS-R5, Cincinnati, OH 45226, telephone (513) 841-4596, fax (513) 841-4506, email: [email protected] | |
| FR Citation | 83 FR 39440 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR